Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aytu BioPharma, Inc. - Common Stock (NQ:AYTU)

2.250 -0.040 (-1.75%)
Streaming Delayed Price Updated: 9:41 AM EDT, Jun 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 550
Open 2.250
Bid (Size) 2.210 (100)
Ask (Size) 2.290 (5,000)
Prev. Close 2.290
Today's Range 2.250 - 2.250
52wk Range 1.650 - 3.065
Shares Outstanding 5,567,490
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Aytu BioPharma to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026
Via ACCESS Newswire
News headline image
Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
Via ACCESS Newswire

Performance

YTD
-18.8%
-18.8%
1 Month
-7.8%
-7.8%
3 Month
-13.8%
-13.8%
6 Month
+0.4%
+0.4%
1 Year
+6.6%
+6.6%

More News

Read More
News headline image
Aytu (AYTU) Q3 2026 Earnings Transcript ↗
Via The Motley Fool
Aytu BioPharma (NASDAQ:AYTU) Surges 23% as EXXUA Launch Gains Early Traction in Mixed Q3 Results ↗
Via Chartmill
Aytu BioPharma Inc (NASDAQ:AYTU) Posts Q2 Revenue Beat Amid EXXUA Launch Costs ↗
Via Chartmill
News headline image
Earnings Scheduled For November 13, 2025 ↗
Via Benzinga
News headline image
Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results
Via ACCESS Newswire
News headline image
Aytu BioPharma to Report Fiscal 2026 Third Quarter Operational and Financial Results on May 13, 2026
Via ACCESS Newswire
News headline image
Aytu BioPharma AYTU Q2 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results
Via ACCESS Newswire
News headline image
Aytu BioPharma Recaps Investor Day Held on January 20, 2026
Via ACCESS Newswire
News headline image
Aytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA
Via ACCESS Newswire
News headline image
Aytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026
Via ACCESS Newswire
News headline image
Aytu BioPharma Details Agenda for Investor Day Scheduled for January 20, 2026 in New York City
Via ACCESS Newswire
News headline image
Aytu BioPharma to Host Investor Day on January 20, 2026 in New York City
Via ACCESS Newswire
News headline image
Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults
Via ACCESS Newswire
News headline image
Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference
Via ACCESS Newswire
News headline image
Aytu BioPharma Inc (NASDAQ:AYTU) Reports Q1 2026 Revenue Beat and Progress on EXXUA Launch ↗
Via Chartmill
News headline image
Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results
Via ACCESS Newswire
News headline image
Insights into Aytu BioPharma's Upcoming Earnings ↗
Via Benzinga
News headline image
Aytu BioPharma to Report Fiscal 2026 First Quarter Operational and Financial Results on November 13, 2025
Via ACCESS Newswire
News headline image
Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)
Via ACCESS Newswire
News headline image
Aytu BioPharma to Present at Upcoming October 2025 Conferences
Via ACCESS Newswire
News headline image
11 Company Presentations Today at The MicroCap Rodeo Conference
Via ACCESS Newswire
News headline image
Aytu BioPharma to Present at Upcoming September 2025 Conferences
Via ACCESS Newswire

Frequently Asked Questions

Is Aytu BioPharma, Inc. - Common Stock publicly traded?
Yes, Aytu BioPharma, Inc. - Common Stock is publicly traded.
What exchange does Aytu BioPharma, Inc. - Common Stock trade on?
Aytu BioPharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aytu BioPharma, Inc. - Common Stock?
The ticker symbol for Aytu BioPharma, Inc. - Common Stock is AYTU on the Nasdaq Stock Market
What is the current price of Aytu BioPharma, Inc. - Common Stock?
The current price of Aytu BioPharma, Inc. - Common Stock is 2.250
When was Aytu BioPharma, Inc. - Common Stock last traded?
The last trade of Aytu BioPharma, Inc. - Common Stock was at 06/09/26 09:41 AM ET
What is the market capitalization of Aytu BioPharma, Inc. - Common Stock?
The market capitalization of Aytu BioPharma, Inc. - Common Stock is 12.53M
How many shares of Aytu BioPharma, Inc. - Common Stock are outstanding?
Aytu BioPharma, Inc. - Common Stock has 13M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.